Industries: Biotech & Pharma
Funding stage: Series A (1 M EUR - < 5 M EUR) Founded: 2012 Employees: -
Business model: R+D+I Services Target: Business
Innovative technology-based research and development in the biomedical application of nanofibers.
Minority stake unknown
Investors: SHIP2B, INVEREADY, UNDISCLOSED FAMILY OFFICES, CAPITAL CELL, CDTI, ENISA, EUROPEAN COMISSION
Minority stake 10.71%
Investors: CROWD-FUNDING INVESTORS
Minority stake unknown %
Investors: ESADEBAN AND OTHER PRIVATE INVESTORS THROUGH CAPITALLCELL
Source: Press releases , newsletters & platforms , company websites , annual reports & accounts , regulatory body sites & stock exchanges
CEO & Founder
We are continually updating our list of new startups so please let us know if you have recently started one.